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Nuclear factor erythroid 2-related factor 2 (NRF2) is a tran-
scription factor that plays a crucial role in protection of cells
fromelectrophile-induced toxicity throughup-regulating phase
II detoxifying enzymes and phase III transporters. We previ-
ously reported that oxidative stress induces up-regulation of
interleukin-11 (IL-11), amember of the IL-6 family that amelio-
rates acetaminophen-induced liver toxicity. However, a role for
IL-11 in protection of cells from electrophile-induced toxicity
remains unclear. Here we show that an environmental electro-
phile, 1,2-naphthoquinone (1,2-NQ), but not 15d-prostaglan-
din J2 (PGJ2) or tert-butylhydroxyquinone (tBHQ), induced
IL-11 production. Consistent with a crucial role for prolonged
ERK activation in H2O2-induced IL-11 production, 1,2-NQ, but
not 15d-PGJ2 or tBHQ, elicited prolonged ERK activation. Con-
versely, inhibition of the ERK pathway by aMEK inhibitor com-
pletely blocked 1,2-NQ-induced IL-11 production at both
protein and mRNA levels, further substantiating an intimate
cross-talk between ERK activation and 1,2-NQ-induced IL-11
production. Promoter analysis of the Il11 gene revealed that two
AP-1 sites were essential for 1,2-NQ-induced promoter activi-
ties. Among various members of the AP-1 family, Fra-1 was up-
regulated by 1,2-NQ, and its up-regulation was blocked by a
MEK inhibitor. Although NRF2 was not required for H2O2-in-
duced IL11 up-regulation, NRF2 was essential for 1,2-NQ-in-
duced IL11 up-regulation by increasing Fra-1 proteins possibly
through promoting mRNA translation of FOSL1. Finally, intra-
peritoneal administration of 1,2-NQ induced body weight loss
in wild-type mice, which was further exacerbated in Il11ra1/
mice compared with Il11ra1/mice. Together, both Fra-1 and
NRF2 play crucial roles in IL-11 production that protects cells
from 1,2-NQ intestinal toxicity.
Electrophiles are electron-deficient compounds that can
accept an electron pair to form a covalent bondwith its reaction
partner (nucleophile), resulting in adducts of macromolecules
(e.g. proteins, lipids, and DNA) (1). Such reactive species have
been shown to be involved in stress, aging, and cancer through
modification of various signaling molecules. It is well recog-
nized that endogenous electrophiles, such as 8-nitro-cGMP,
15-deoxy-prostaglandin J2 (15d-PGJ2),3 andnitrated fatty acids,
are produced during oxidative stress and inflammation (2, 3)
and then activate redox signal transduction pathways associ-
ated with up-regulation of antioxidant and anti-inflammation
genes (1–3). In addition, there are a variety of electrophiles in
the environment (4, 5). For example, particles with an aerody-
namic diameter of 2.5 m or less (PM2.5) and tobacco smoke
(6) contain an atmospheric electrophile, 1,2-naphtoquinone
(1,2-NQ), that activates epidermal growth factor receptor
(EGFR) through S-arylation of Cys-121 of protein-tyrosine
phosphatase 1B (PTP1B) (7). A transcription factor, NF-E2-
related factor 2 (NRF2), is activated and attenuates electro-
phile-induced toxicity through inducing phase II-detoxifying
enzymes and phase III transporters (8, 9). Under normal con-
ditions, NRF2 is sequestered by an E3 ligase, Keap1, and is con-
stitutively degraded by the proteasome. Once the cysteine res-
idues on Keap1 are modified by electrophiles, Cul3-dependent
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ubiquitination of NRF2 is attenuated, thereby rescuing newly
synthesized NRF2 from proteasomal degradation and allowing
translocation of NRF2 into the nucleus. NRF2 binds to a
cognate DNA regulatory element termed the antioxidant
response element and up-regulates its target genes. Of inter-
est, 1,2-NQ also activates NRF2 through covalent modifica-
tion of Keap1 (10). Collectively, it seems likely that there
are different adaptive responses against environmental elec-
trophiles, such as 1,2-NQ, via activating signal transduction
pathways.
Interleukin-11 (IL-11) is a member of the IL-6 family cyto-
kines and controls various cellular responses, including hema-
topoiesis, bone development, tissue repair, and carcinogenesis
(11). IL-11 binds to the IL-11 receptor1 (IL-11R1) and gp130
complex and activates the family of signal transducer and acti-
vator of transcription (STAT) proteins.We previously reported
that IL-11 is produced by hepatocytes in an oxidative stress-de-
pendentmanner and ameliorates acetaminophen-induced liver
injury (12). In addition, IL-11 treatment prevents cardiac dys-
function and attenuates oxidative stress after ischemia and rep-
erfusion injury in heart (13). Together, these results suggest
that IL-11 acts as a protective cytokine against oxidative stress-
induced tissue injury.However, it is unclearwhether IL-11 con-
tributes to protection of cells against electrophile-induced tox-
icity. We previously reported that 1,2-NQ activates the MEK/
ERK pathway through modification and subsequent activation
of epidermal growth factor receptor (14). Given that expression
of Il11 is regulated by theMEK/ERK pathway (12), we surmised
that 1,2-NQ might induce IL-11 production.
We found that 1,2-NQ, but not tBHQ or 15d-PGJ2, induced
IL-11 expression at bothmRNA and protein levels.We showed
that 1,2-NQ-induced up-regulation of Il11 mRNA largely
depended on phosphorylation of ERK and subsequent induc-
tion of Fra-1. Moreover, knockdown of NRF2 by siRNA com-
pletely abolished 1,2-NQ-induced IL11 induction. Conversely,
overexpression of NRF2 induced Il11 reporter gene activation.
Unexpectedly, we found that knockdown of NRF2 abolished
expression of Fra-1 proteins before or after 1,2-NQstimulation,
whereas overexpression of NRF2 alone induced an increase in
Fra-1 proteins. Finally, 1,2-NQ-induced body weight loss and
intestinal toxicity were exacerbated in Il11ra1/ mice com-
pared with control Il11ra1/mice. Together, these data sug-
gest that NRF2 plays a crucial role in IL11 up-regulation
through increasing Fra-1 proteins.
Results
An Electrophile Induces IL-11 Expression—To test whether
electrophiles increase Il11 expression, we treated a murine
colon cancer cell line, CT26, and a human hepatoma cell line,
HepG2, with several electrophiles, including 15d-PGJ2, tBHQ,
and 1,2-NQ. To be precise, tBHQ is not an electrophile but is
easily converted to an electrophilic quinone through autoxida-
tion. As expected, all three electrophiles induced accumulation
of NRF2 (Fig. 1A and supplemental Fig. 1) and significantly
increased expression of an NRF2 target gene, Hmox1, in CT26
and HepG2 cells (Fig. 1, B andC). Intriguingly, 1,2-NQ, but not
15d-PGJ2 or tBHQ, increased expression of Il11 mRNA in
CT26 and HepG2 cells (Fig. 1, B and C). Moreover, we found
that 1,2-NQ induced the production of IL-11 protein in CT26
and HepG2 cells (Fig. 1D).
Activation of the ERK Pathway Is Required for 1,2-NQ-in-
duced Il11 Up-regulation—To investigate the molecular mech-
anisms underlying 1,2-NQ-induced Il11mRNA expression, we
sought to identify the signaling pathways leading to Il11 expres-
sion.We previously reported thatH2O2-induced IL-11 produc-
tion largely depends on the ERKpathway (12).We also reported
that 1,2-NQ induces ERK activation by inactivating PTP1B
through modification of a cysteine residue of PTP1B (7). As
shown in Fig. 2A, 1,2-NQ induced phosphorylation of JNK,
ERK, AKT, and to a lesser extent p38 in CT26 cells, whereas
1,2-NQ only induced phosphorylation of ERK in HepG2 cells.
We next tested the effects of various MAP kinase inhibitors on
1,2-NQ-induced Il11 induction in these cells. Inhibition of the
MEK/ERK pathway with aMEK inhibitor, U0126, almost com-
pletely abolished 1,2-NQ-induced Il11 up-regulation in both
cells (Fig. 2B). Surprisingly, inhibition of the p38MAPK path-
way by SB230580 strongly up-regulated expression of Il11
mRNA in HepG2, but not CT26 cells, although the mechanism
was not investigated in this study. We also found that strong
and sustained ERK activation was only observed in 1,2-NQ-
stimulated, and not 15d-PGJ2- or tBHQ-stimulated, CT26 and
HepG2 cells (Fig. 2C).
Two AP-1 Sites Are Essential for 1,2-NQ-induced Il11 Gene
Promoter Activity—To further clarify themechanisms underly-
ing 1,2-NQ-dependent Il11 expression, we tested whether
1,2-NQ could activate a luciferase reporter under the control of
the 1.3 kb fragment of murine Il11 promoter (Fig. 3A). Il11
gene promoter activity was increased by 1,2-NQ treatment, and
this increase was almost completely abolished in the presence
of U0126 (Fig. 3B). Given that the Il11 promoter contains two
AP-1 binding sites and the MAPK pathway induces activation
of AP-1 (15), we introduced mutation of each element alone or
a combination of them (Fig. 3A). As expected, mutation of each
AP-1 element alone partially reduced, and both mutations
of two AP-1 sites completely abolished, a 1,2-NQ-induced
increase in promoter activities (Fig. 3C). Moreover, 1,2-NQ
could activate a luciferase reporter containing the0.8 kb frag-
ment of the murine Il11 promoter containing two wild-type
AP-1 sites but not two AP-1 mutants (Fig. 3D). These data sug-
gest that two AP-1 sites are required for 1,2-NQ-induced Il11
induction.
Fra-1 Is Required for Induction of Il11—TheAP-1 is a dimeric
transcriptional factor complex that is composed of Fos and Jun
family proteins (15). Moreover, the MEK/ERK pathway regu-
lates Fos and Jun family protein levels. We examined whether
1,2-NQ treatmentmight affect protein levels ofmembers of the
Fos and Jun family in CT-26 and HepG2 cells in the absence or
presence of U0126. Whereas c-Fos, FosB, c-Jun, and JunD pro-
tein levels remained constant after 1,2-NQ treatment, expres-
sion of Fra-1 was increased by treatment with 1,2-NQ, and this
increase was suppressed by U0126 pretreatment (Fig. 4A and
supplemental Fig. 2). In addition, quantitative PCR showed that
1,2-NQ treatment increased expression of Fosl1 encoding Fra-1
protein along with Il11 expression, and this increase was sup-
pressed byU0126 treatment in CT26 andHepG2 cells (Fig. 4B).
NRF2 and Interleukin-11 Production
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These results suggest that 1,2-NQ up-regulated Fra-1 at both
mRNA and protein levels in a MEK/ERK-dependent manner.
We next performed an electrophoretic mobility shift assay
(EMSA) using nuclear extracts from 1,2-NQ-treated HepG2
cells and an oligonucleotide probe containing two AP-1 sites of
the Il11 promoter. 1,2-NQ induced a retarded complex con-
taining labeled AP-1 oligonucleotides that disappeared in the
presence of U0126 (Fig. 4C). Moreover, we found that the com-
plex was supershifted with the addition of antibodies against
Fra-1, JunB, or JunD, suggesting that the 1,2-NQ-induced
nuclear complex is at least composed of Fra-1, JunB, and JunD.
To further investigate whether these transcriptional factors are
involved in Il11 expression, we knocked down expressions of
each gene by respective siRNA.Whereas knockdown of Junb or
Jund by the respective siRNA did not suppress, but rather
enhanced, 1,2-NQ-induced Il11 expression (supplemental Fig.
3), knockdownof FOSL1 by siRNA significantly suppressed 1,2-
NQ-induced FOSL1 and IL11mRNA expression (Fig. 4D). Fur-
thermore, a chromatin immunoprecipitation (ChIP) assay
revealed that Fra-1was recruited to the Il11promoter following
1,2-NQ as well as H2O2 stimulation (Fig. 4E).
We finally compared expression of phosphorylated and
total Fra-1 in CT-26 and HepG2 cells after treatment with
15d-PGJ2, tBHQ, and 1,2-NQ. As expected, 1,2-NQ, but not
15d-PGJ2 or tBHQ, increased both phosphorylated and total
Fra-1 in CT26 cells and, to a lesser extent, HepG2 cells
(supplemental Fig. 4).
NRF2 Is Required for 1,2-NQ-induced IL11 Expression—A
previous study has shown that the murine glutathione S-trans-
ferase Ya subunit gene promoter contains the AP-1-like sites
that partially overlapped with the antioxidant response ele-
ment, and Gst Ya expression is induced by PMA and electro-
philes (16). Given that one of the two AP-1 sites in the Il11
promoter overlapped with the consensus sequence of NRF2
binding sites (17) (Fig. 5A), we tested whether NRF2 could acti-
vate a luciferase reporter under the control of the Il11 pro-
moter. Overexpression ofNRF2 activated reporter vectors con-
taining 1.3 or 0.8 kb fragments of the Il11 promoter in a
dose-dependentmanner (Fig. 5B).Moreover, NRF2-dependent
promoter activity was abolished in a reporter vector, in which
mutations of two AP-1 sites were introduced (Fig. 5B). We
finally knocked down expression of NRF2 by siRNA in HepG2
FIGURE 1. IL-11 is induced by 1,2-NQ. A–C, CT26 and HepG2 cells were stimulated with 15d-PGJ2 (10M), tBHQ (100M), or 1,2-NQ (50M) for the indicated
times. A, cell lysates were analyzed by immunoblotting with the indicated antibodies. B and C, RNAs were extracted from CT26 (B) or HepG2 (C) cells. Relative
amounts of Hmox1 and Il11 mRNAs were determined by qPCR. Results are mean  S.D. (error bars) of triplicate samples. D, CT26 and HepG2 cells were
stimulated with the indicated concentrations of 1,2-NQ (M) for 18 h. Concentrations of IL-11 in the culture supernatants were determined by ELISA. Results
aremeanS.D. of triplicate samples. *,p0.05; **,p0.01; ***,p0.001;ns, not significant versusuntreatedcells. All results are representativeof twoor three
independent experiments.
NRF2 and Interleukin-11 Production
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cells (Fig. 5C). Knockdown of NRF2 by two different siRNAs
significantly decreased expression ofNRF2mRNA and blocked
1,2-NQ-induced up-regulation of NRF2 at protein levels (Fig.
5C). Moreover, knockdown of NRF2 abolished 1,2-NQ-in-
duced IL11 induction. In sharp contrast, H2O2-induced IL11
expression was not blocked in NRF2-knocked down cells (Fig.
5D). These results suggest thatNRF2 is essential for 1,2-NQbut
not H2O2-induced Il11 expression.
NRF2 Is Not Recruited to the IL11 Promoter and Does Not
Interact with Fra-1—The fact that NRF2 activated transcrip-
tion of IL11 mRNA prompted us to tested whether NRF2 was
recruited to the IL11 promoter after 1,2-NQ treatment by a
ChIP assay. Anti-NRF2 antibody efficiently precipitated the
promoter, but not an unrelated region of NAD(P)H:quinone
oxidoreductase 1 (NQO1), a canonical target gene of NRF2,
after 1,2-NQ stimulation (Fig. 6A). However, under these
experimental conditions, the promoter of IL11 was not precip-
itated with anti-NRF2 antibody after 1,2-NQ stimulation
(Fig. 6A).
We next tested the possibility that NRF2 might be recruited
to the IL11 promoter via interaction with Fra-1. To test this
possibility, we transiently transfected an expression vector
for Myc-tagged NRF2 along with FLAG-tagged Fra-1 into
HEK293T cells. Moreover, to test a possibility that phosphory-
lation of Fra-1 might affect its binding to NRF2, we co-trans-
fected expression vectors for Myc-tagged NRF2, FLAG-tagged
Fra-1, HA-tagged constitutively active MEKK1 (MEKK1N),
and HA-tagged ERK2. Consistent with our previous study (12),
HA-tagged ERK2 was efficiently immunoprecipitated with
FLAG-tagged Fra-1 (Fig. 6B). In sharp contrast, anti-FLAG
antibody could not immunoprecipitateMyc-taggedNRF2, sug-
gesting that NRF2 could not interact with either phosphorylat-
ed or unphosphorylated Fra-1 at least under our experimental
conditions. These results suggest that NRF2 does not appear to
be directly or indirectly recruited to the IL11 promoter.
Knockdown of NRF2 Abolishes Expression of Fra-1 Proteins
but Not FOSL1 mRNAs—The fact that NRF2 was not recruited
to the IL11 promoter following 1,2-NQ stimulation or did not
interact with Fra-1 (Fig. 6) prompted us to test whether NRF2
might regulate expression of Fra-1 at mRNA or protein levels.
Intriguingly, a very recent study has shown thatNRF2promotes
mRNA translation of a particular set of genes (18). Although
knockdown of NRF2 by siRNA did not affect FOSL1 mRNA
expression (Fig. 7A), knockdown of NRF2 abolished Fra-1
expression at protein levels (Fig. 7B). In sharp contrast, expres-
sions of c-Fos, STAT3, pERK, or total ERK were not decreased
in NRF2-knockdown cells. This suggests that NRF2 might
increase Fra-1 proteins through preventing degradation of
Fra-1 by the ubiquitin-proteasome pathway or enhancemRNA
translation of FOSL1.
To discriminate between these two possibilities, we next
tested the effect of knockdown of NRF2 on expression of Fra-1
proteins in the absence or presence of a proteasome inhibitor,
MG132. Because unphosphorylated Fra-1 is constitutively
degraded by the ubiquitin-proteasome pathway (12), hypo-
phosphorylated Fra-1 accumulated in the presence of
MG132 (Fig. 7B). Notably, even in the presence of MG132,
Fra-1 was decreased in NRF2-knockdown cells, suggesting
FIGURE 2. The ERK pathway is crucial for 1,2-NQ-induced IL-11 production. A, CT26 and HepG2 cells were stimulated with 1,2-NQ for the indicated times,
and cell lysates were analyzed by immunoblotting with the indicated antibodies. B, CT26 and HepG2 cells were stimulated with 1,2-NQ in the absence or
presence (final concentration, 20 M) of SP600125 (SP; a JNK inhibitor), SB203580 (SB; a p38 inhibitor), U0126 (U01; a MEK inhibitor), or LY294002 (LY; a PI3K
inhibitor) for 2 h. RNAs were extracted from CT26 and HepG2 cells, and expression of Il11 was determined by qPCR. Results are mean  S.D. (error bars) of
triplicate samples. *, p 0.05; ***, p 0.001;ns, not significant versus 1,2-NQ-treated cells in the absence of inhibitors.C, CT26 andHepG2 cellswere stimulated
with 15d-PGJ2, tBHQ, or 1,2-NQ as in Fig. 1A for the indicated time points, and cell lysates were analyzed by immunoblotting with the indicated antibodies.
NRF2 and Interleukin-11 Production
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that NRF2 did not block degradation of Fra-1 by the ubiqui-
tin-proteasome pathway. Conversely, overexpression of
NRF2 increased Fra-1, but not c-Fos, STAT3, pERK, or ERK
proteins (Fig. 7C). Together, NRF2 increases expression of
Fra-1, possibly through up-regulating its translation, thereby
inducing IL11 expression.
Administration of 1,2-NQ Induces Il11 Expression and
Enhances Proliferation of Intestinal Epithelial Cells (IECs) in the
Cecum—To investigate the biological consequences of 1,2-NQ-
dependent IL-11 production in vivo, wild-type mice were
injected intraperitoneally with 1,2-NQ. Compared with oil-
treated mice, 1,2-NQ-treated mice exhibited body weight loss
72 h after injection (Fig. 8A). To our surprise, histology of small
intestine and colon appeared to be normal in 1,2-NQ-treated
mice (data not shown). In sharp contrast, 1,2-NQ administra-
tion induced dilatation of the cecum and increased numbers of
apoptotic IECs (Fig. 8, B–D). Moreover, numbers of Ki67- and
cyclin D1-positive proliferating IECs were significantly
increased in the cecum of mice compared with untreated mice
(Fig. 8, E and F). Under these experimental conditions, we
examined whether 1,2-NQ induced expression of Il11 and
Hmox1 mRNAs in the cecum. Consistent with in vitro data,
administration of 1,2-NQ into wild-type mice resulted in up-
regulation of Il11 and Hmox1 mRNAs (Fig. 8G). These results
suggest that 1,2-NQadministrationsmay enhance proliferation
of IECs through up-regulation of IL-11.
Exacerbation of 1,2-NQ-induced Intestinal Toxicity in
Il11ra1/ Mice—To test whether production of IL-11 by
1,2-NQ might attenuate 1,2-NQ-induced intestinal injury, we
next administered 1,2-NQ into Il11ra1/mice. We first con-
firmed that numbers of apoptotic cells and proliferating cells of
IECs were not different between Il11ra1/ and Il11ra1/
mice under normal conditions (Fig. 9, D and F). Body weight
loss was significantly exacerbated in 1,2-NQ-treated
Il11ra1/ mice compared with Il11ra1/ mice (Fig. 9A).
Whereas numbers of apoptotic cells were decreased in
Il11ra1/mice comparedwith Il11Ra1/mice (Fig. 8,B–D),
numbers of Ki67- and cyclin D1-positive proliferating cells
were severely decreased in the cecum of Il11ra1/mice com-
paredwith Il11ra1/mice (Fig. 9, E and F). Given that 1,2-NQ
increased the number of both apoptotic and proliferating cells
in wild-type mice, together these results suggest that 1,2-NQ
promotes turnover of IECs, resulting in apoptosis of IECs
through up-regulation of IL-11.
Discussion
In the present study, we showed that 1,2-NQ induced IL-11
expression in anMEK/ERK-dependentmanner. Both Fra-1 and
NRF2 were essential for 1,2-NQ-induced IL-11 production,
although the mechanisms underlying Fra-1- and NRF2-depen-
dent up-regulation of IL11 mRNA appeared to be different.
Upon stimulation of cells with 1,2-NQ, Fra-1 was recruited to
the Il11 promoter and acted as a transcription factor. In sharp
contrast, NRF2 was not recruited to the IL11 promoter but
increased translation of the FOSL1 transcript, which subse-
quently increased expression of Fra-1 proteins. Moreover,
given that electrophile-induced intestinal toxicity was exacer-
bated in Il11ra1/ mice compared with Il11ra1/ mice,
IL-11 protects cells against electrophile-induced as well as oxi-
dative stress-induced tissue injury.
We previously reported that 1,2-NQ induces ERK activation
through modification of PTP1B and subsequent activation of
EGFR (14). Although 1,2-NQ, 15d-PGJ2, and tBHQ activated
the NRF2 pathway, only 1,2-NQ induced IL-11 production.
Although tBHQ induced prolonged ERK activation in HepG2
cells, levels of ERKphosphorylation induced by tBHQwere very
low compared with those induced by 1,2-NQ (Fig. 2C). Thus,
we surmise that levels of ERK phosphorylation were not suffi-
cient to induce IL-11 production, at least under our experimen-
tal conditions. Notably, inhibition of the MEK/ERK pathway
blocked 1,2-NQ-induced up-regulation of Fra-1 and IL-11 at
both mRNA and protein levels. Given that knockdown of Fosl1
inhibited 1,2-NQ-induced IL-11 production, the MEK/ERK/
Fra-1 pathway is crucial for 1,2-NQ- as well as H2O2-induced
IL-11 production (12).
The mechanisms underlying prolonged ERK activation by
1,2-NQ, but not other agents tested here, are not fully investi-
gated in the present study. In this respect, quinones exhibit two
chemical properties, including those of an electrophile and
electron transfer agent. Thus, quinones transfer electrons from
a reducing agent, such as NADPH, to oxygen, resulting in gen-
eration of superoxides that are finally converted to hydrogen
peroxide. Consistently, a previous study has reported that
1,2-NQ induces hydrogen peroxide-dependent oxidation of
FIGURE 3. Two AP1 sites are essential for 1,2-NQ-induced IL-11 produc-
tion. A, schematic diagrams of reporter vectors, sequences of two AP-1 sites,
and their mutants. B, HepG2 cells were transfected with a 1.3 kb reporter
vector and then untreated or treated with 1,2-NQ in the absence or presence
of U0126 (20 M) for 18 h. Luciferase activities were calculated, and relative
luciferase activities are expressed as -fold activation comparedwith unstimu-
lated cells. Results are mean S.D. (error bars) of triplicate samples. ***, p
0.001 versus1,2-NQ-treated cells in the absenceofU0126.C, HepG2 cellswere
transfectedwith the indicated reporter vectors and then stimulated and ana-
lyzed as in B. ***, p  0.001 versus 1,2-NQ-treated cells transfected with the
1.3 kb reporter vector. D, HepG2 cells were transfected with the indicated
reporter vectors and stimulated with the indicated concentrations of 1,2-NQ
and then analyzed as in B. ***, p 0.001; ns, not significant versus untreated
cells transfected with each reporter vector.
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protein thiols corresponding to sulfenic acid in the cells (19).
Given that hydrogen peroxide is responsible for prolonged ERK
activation (12), 1,2-NQ-dependent production of hydrogen
peroxide, in concert with activation of EGFR, might be res-
ponsible for 1,2-NQ-induced ERK activation. Further study is
required to address this issue.
One of themost important findings of this study is thatNRF2
contributes to 1,2-NQ-induced IL-11 production. An essential
role for NRF2 in 1,2-NQ-induced IL-11 production is sup-
ported by the following findings. First, 1,2-NQ induced accu-
mulation of NRF2. Second, overexpression of NRF2 activated
the IL11 gene promoter activities via AP-1 sites, which contain
a putative NRF2 consensus motif. Third, knockdown of NRF2
by siRNAs blocked 1,2-NQ-induced IL11 up-regulation. How-
ever, we could not detect either the recruitment of NRF2 to the
IL11 promoter by a ChIP assay or interaction of NRF2 with
Fra-1. To our surprise, we found that knockdown ofNRF2 abol-
ished expression of Fra-1 proteins but not FOSL1mRNA levels.
Moreover, a proteasome inhibitor did not suppress a decrease
in Fra-1 in NRF2-knockdown cells, suggesting that NRF2 did
not appear to up-regulate Fra-1 through preventing the degra-
dation of Fra-1 by the ubiquitin-proteasome.A recent study has
shown that NRF2 promotes mRNA translation of several genes
through preventing oxidative stress-dependent blockade of
assembly of the translation initiation complex in pancreatic
cancer (18). Thus, it is reasonable to hypothesize that NRF2
promotesmRNA translation of FOSL1, thereby increasing pro-
tein expression of Fra-1. Further study will be required to elu-
cidate the detailed mechanism whereby NRF2 regulates Fra-1
expression.
Constitutive activation of the NRF2 pathway and elevated
expression of IL-11 are tightly associated with the development
of cancer (11, 20), IL-11 might contribute, at least in part, to
NRF2-dependent oncogenesis in a context-dependentmanner.
Intriguingly, knockdown of NRF2 could not suppress H2O2-
induced IL11 up-regulation. Although Fra-1 is essential for
FIGURE 4. Fra-1 is essential for 1,2-NQ-induced IL-11 expression. A and B, CT26 and HepG2 cells were stimulated with 1,2-NQ (50 M) in the absence or
presence of U0126 (10 M) for the indicated times. A, cell lysates were analyzed by immunoblotting with the indicated antibodies. B, relative amounts of Il11
and Fosl1 mRNAs were determined by qPCR. Results are mean  S.D. (error bars) of triplicate samples. *, p  0.05; ***, p  0.001; ns, not significant versus
DMSO-treated cells.C, HepG2cellswere stimulatedas inA. Nuclear extractswerepreparedandpreincubatedwith the indicatedantibodies and then incubated
with 32P-labeled AP-1 oligonucleotides. The DNA-protein complexes were subjected to EMSA. C and F, oligonucleotide-protein complexes and free oligonu-
cleotides, respectively. *, nonspecific complex.D, HepG2 cellswere transfectedwith control or FOSL1 siRNAs. At 48 h after transfection, cellswere unstimulated
or stimulated with 1,2-NQ (50 M) for 4 h. Expression of Fra-1 in control or FOSL1 siRNAs-treated cells was analyzed by immunoblotting with the indicated
antibodies. Relative amounts of FOSL1 and IL11mRNAswere determined by qPCR and analyzed as in B. *, p 0.05; ***, p 0.001 versus 1,2-NQ-treated control
siRNA-transfected cells. E, Fra-1 is recruited to the Il11 promoter following H2O2 or 1,2-NQ stimulation. CT26 cells were stimulated with H2O2 (1 mM) or 1,2-NQ
(15M) for 2 h, and then cells were subjected to ChIP assays using control Ig or anti-Fra-1 antibody. Immunoprecipitated fragments of the Il11 promoters were
determinedbyqPCR. Enrichment of thepromoter fragmentswas expressed as a percentageof input. Results aremean S.D. of triplicate samples. **,p 0.01;
***, p  0.001 compared with untreated cells. C and F, control Ig and anti-FLAG antibody, respectively. All results are representative of two independent
experiments.
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both 1,2-NQ- andH2O2-induced IL-11 production (12) (in this
study), different transcription factors induced by H2O2 or
NRF2 in concert with Fra-1 might mediate IL-11 production in
a stimulus-dependent manner.
Intraperitoneal injection of 1,2-NQ resulted in dilatation of
the cecum along with severe weight loss of wild-type mice. We
found that the number of apoptotic IECs was increased in the
cecum of 1,2-NQ-treated wild-type mice compared with
untreated mice. Under normal conditions, IECs move toward
the tip of the villi and undergo apoptosis, followed by shedding
into the lumen of the intestine. Numbers of Ki67- and cyclin
D1-positive proliferating IECs were significantly increased in
1,2-NQ-treated wild-typemice compared with untreatedmice,
suggesting that an increase in apoptotic IECs might not be a
primary event but rather a secondary event induced by an
increased turnover of IECs after 1,2-NQ treatment. Consistent
with this idea, numbers of both apoptotic and proliferating
IECs were reduced in Il11ra1/ mice compared with
Il11ra1/ mice. Our preliminary experiments showed that
injection of recombinant IL-11 up-regulated expression of
Reg3b and Reg3g in the intestines (data not shown). Given that
Reg3 and Reg3 act as antimicrobial proteins and promote
tissue repair (21, 22), IL-11 might attenuate 1,2-NQ-induced
intestinal toxicity through up-regulation of Reg3b and Reg3g. It
is currently unknown why intestinal toxicity was relatively
restricted to the cecum and not the small intestine or colon.
Further study is required to address this issue.
Experimental Procedures
Reagents—U0126 (Merck), SB230580 and SP600125 (Calbi-
ochem), 15d-PGJ2 (Cayman Chemical), tBHQ (WAKO),
1,2-NQ (Tokyo Kasei Industries), MG132 (Biomol), and
LY294002 (Biomol) were purchased from the indicated
sources. Antibodies used were against NRF2 (sc-13032, Santa
Cruz Biotechnology, Inc.), phospho-ERK (catalog no. 9101),
total ERK (catalog no. 9102), phospho-JNK (catalog no. 9251),
total JNK (catalog no. 9252), phospho-p38 (catalog no.
9211), total p38 (catalog no. 9212), phospho-AKT (catalog no.
9271), total AKT (catalog no. 9272), c-Fos (sc-52, Santa Cruz
Biotechnology), c-Jun (catalog no. 9162), phospho-Fra-1 (cata-
log no. 3880), Fra-1 (sc-605 and sc-183, Santa Cruz Biotechnol-
ogy), FosB (sc-7203, Santa Cruz Biotechnology), JunB (sc-8051,
Santa Cruz Biotechnology), JunD (sc-74, Santa Cruz Biotech-
nology), cleaved caspase-3 (catalog no. 9661), Ki67 (ab16667,
Abcam), cyclin D1 (ab16663, Abcam), tubulin (T5168, Sigma-
Aldrich), anti-FLAG (F3165, Sigma-Aldrich), anti-HA (3F10
FIGURE 5.NRF2 is essential for 1,2-NQ-induced IL-11 production.A, a putative NRF2-binding site is partially overlappedwith the 5AP-1 site. B, HepG2 cells
were transfectedwith an empty vector or graded amounts (0.1, 0.3, and 1.0g/sample) of an expression vector forMyc-taggedNRF2 alongwith the indicated
reporter vectors. Luciferase activities were calculated 18 h after transfection, and relative luciferase activities are expressed as -fold activation compared with
empty vector-transfected cells. Results aremean S.D. (error bars) of triplicate samples. ***,p0.001;ns, not significant versus control vector-transfected cells.
C, knockdown of NRF2 by siRNA suppresses 1,2-NQ-induced Il11 mRNA induction. HepG2 cells were transfected with control siRNA or two different siRNAs
against NRF2. At 48 h after transfection, cells were unstimulated or stimulated with 1,2-NQ (50 M) for 4 h. Relative amounts of NRF2 or IL11 mRNAs were
determined by qPCR. Results are mean  S.D. of triplicate samples. ***, p  0.001 versus control siRNA-transfected cells. Cell lysates were analyzed by
immunoblotting with the indicated antibodies. D, knockdown of NRF2 by siRNA does not suppress H2O2-induced Il11 mRNA induction. HepG2 cells were
transfectedwith siRNAs as inC and stimulatedwithH2O2 (1mM) for 4 h. Relative amounts ofNRF2or IL11mRNAsweredeterminedbyqPCR. Results aremean
S.D. of triplicate samples. **, p  0.01; ns, not significant versus control siRNA-transfected cells. All results are representative of two or three independent
experiments.
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and 12CA5, Roche Applied Science), anti-Myc (sc-40, Santa
Cruz Biotechnology), biotin-conjugated anti-rabbit IgGs (E0432,
DakoCytomation), HRP-conjugated streptavidin (P0397,
DakoCytomation), and HRP-conjugated anti-rabbit IgGs (GE
Healthcare). Unless otherwise indicated, antibodies were pur-
chased from Cell Signaling Technology.
Cell Culture—CT26, HepG2, and human embryonic kidney
(HEK) 293T cells were maintained in DMEM containing 10%
fetal calf serum (FCS). Cells were stimulated with 15d-PGJ2 (10
M), 1,2-NQ (50 M), or tBHQ (100 M) in the absence or
presence of SP600125 (20 M), SB230580 (20 M), U0126 (20
M), LY294002 (20 M), or MG132 (10 M) for the indicated
times. 1,2-NQwas freshly dissolved inDMSOandused for each
experiment.
Mice—Il11ra1/ mice were provided by L. Robb and
described previously (23), and they were back-crossed to
C57BL/6 mice for at least 7 generations. C57BL/6 mice were
purchased from Japan-SLC. All experiments were performed
according to the guidelines approved by the Institutional Ani-
mal Experiment Committee of Juntendo University School of
Medicine and Toho University School of Medicine.
Western Blotting—Cells were lysed in a radioimmune precip-
itation assay buffer (50 mM Tris-HCl, pH 8.0, 150 mMNaCl, 1%
Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 25 mM -glycero-
phosphate, 1mM sodiumorthovanadate, 1mM sodium fluoride,
1 mM PMSF, 1 g/ml aprotinin, and 1 g/ml leupeptin). After
centrifugation, cell lysates were subjected to SDS-PAGE and
transferred onto polyvinylidene difluoride membranes (Milli-
pore). Themembranes were immunoblottedwith the indicated
antibodies. The membranes were developed with Super Signal
West Dura extended duration substrate (Thermo Scientific)
and analyzed by a LAS4000 (GEHealthcare) or AmershamBio-
sciences imager (GE Healthcare). In some experiments, blots
were quantified using ImageJ version 1.49 (National Institutes
of Health).
Quantitative PCR (qPCR) Assays—Total RNAs were ex-
tracted from CT26 and HepG2 cells or the cecum frommice of
the indicated genotype. cDNAs were synthesized with the
ReverTra Ace qPCR RT kit (Toyobo). qPCR analysis was per-
formed with the 7500 Fast Real-Time PCR detection system
with the SYBR Green method of the target genes together with
an endogenous control, murine Hprt or human GAPDH, with
7500 SDS software (Applied Biosystems). The following
primers were used in this study: murineHmox1, 5-GTCAAG-
CACAGGGTGACAGA-3 and 5-ATCACCTGCAGCTCCT-
CAAA-3; humanHMOX1, 5-AAGATTGCCCAGAAAGCC-
CTGGAC-3 and 5-AACTGTCGCCACCAGAAAGCTGAG-
3; murine Il11, 5-CTGCACAGATGAGAGACAAATTCC-3
and 5-GAAGCTGCAAAGATCCCAATG-3; human IL11,
5-GTGGCCAGATACAGCTGTCGC-3 and 5-GGTAGGA-
CAGTAGGTCCGCTC-3; murine Fosl1, 5-TAAGGCGCG-
AGCGGAACAAG-3 and 5-TCGCTGCAGCCCAGATTT-
FIGURE 6. NRF2 is neither recruited to the IL11 promoter nor interacts with Fra-1. A, NRF2 is not recruited to the IL11 promoter after 1,2-NQ stimulation.
HepG2 cells were stimulated with the indicated concentrations of 1,2-NQ (50 M) for 2 h, and then cells were subjected to ChIP assays using control Ig or
anti-NRF2 antibody. Immunoprecipitated fragments of the NQO1 and IL11 promoters or an unrelated region of NQO1were analyzed by qPCR. Enrichment of
the promoter fragments was expressed as a percentage of input. Results are mean S.D. (error bars) of triplicate samples. *, p 0.05; ***, p 0.001; ns, not
significant versus untreated cells. Results are representative of four independent experiments. B, Fra-1 interacts with ERK2, but not NRF2. HEK293T cells were
transiently transfectedwith the indicatedexpressionvectors, and lysateswere immunoprecipitated (IP)with the indicatedantibodies. Co-immunoprecipitated
proteins were analyzed by immunoblotting with the indicated antibodies. Expression of transfected proteins was verified by immunoblotting with the
indicated antibodies using total cell lysates. Arrowheads and asterisks, phosphorylated and unphosphorylated Fra-1, respectively. C and F, control Ig and
anti-FLAG antibody, respectively. Results are representative of three independent experiments.
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CTC-3; human FOSL1, 5-TCGCTGCAGCCCAGATTT-
CTC-3 and 5-CTGCTGCTGTCGATGCTTG-3; human
NRF2 (NFE2L2), 5-TGCCCCTGGAAGTGTCAAACA-3 and
5-CAACAGGGAGGTTAATGATTT-3; murine Hprt, 5-
AACAAAGTCTGGCCTGTATCC AA-3 and 5-GCAGTA-
CAGCCCCAAAATGG-3; human GAPDH, 5-AGCCACA-
TCGCTCAGACAC-3 and 5-GCCCAATACGACCAA-
ATCC-3.
ELISA—CT26 cells and HepG2 cells were stimulated with
1,2-NQ (50 M) for 18 h. Concentrations of murine IL-11 and
human IL-11 in the culture supernatants were determined by
ELISA according to the manufacturer’s instructions (R&D
Systems).
Knockdown of Target Genes by siRNAs—CT26 or HepG2
cells were transfected with the indicated siRNAs using Lipo-
fectamine 2000 (Invitrogen) at a final concentration of 50 nM.
At 24 or 36 h after transfection, themediumwas changed to 1%
FCS-containing DMEM, and then cells were stimulated
with 1,2-NQ for the indicated times. Control (Gfp) siRNA
(D-001300-01) and ON-TARGETplus SMARTpool siRNAs
targeting human FOSL1 (L-004341) and murine Jund (L-
054829) and Stealth RNAiTM siRNA negative control and Med
GC and Stealth siRNAs targeting human NRF2 (NFE2L2)
(HSS181506 and HSS107130) and murine Junb (MSS247328
and MSS247330) were purchased from Thermo Fisher Scien-
tific. The efficiency of siRNAswas analyzed by immunoblotting
with the indicated antibodies using cell lysates or qPCR
analysis.
EMSA—EMSA was performed as described previously (24).
Briefly, nuclear extracts were prepared from unstimulated or
1,2-NQ-stimulated HepG2 cells in the absence or presence of
U0126. The two AP-1-containing oligonucleotides (5-AGGG-
AGGGTGAGTCAGGATGTGTCAGGCC-3 and 5-AGGG-
CGGCCTGACACATCCTGACTCACCCT-3) were labeled
with T4 polynucleotide kinase in the presence of [-32P]ATP
(PerkinElmer Life Sciences). Then nuclear extracts were incu-
batedwith the labeled oligonucleotides. The composition of the
AP-1 complex was examined by supershift analysis with the
indicated antibodies.
Luciferase Assay—The reporter vectors containing the
murine Il11 gene promoter upstream of luciferase, including
pGL3-Il11 (1.3 kb) (1094/134), pGL3-Il11 (1.3 kb, M1),
pGL3-Il11 (1.3 kb, M2), and pGL3-Il11 (1.3 kb, M1M2),
were described previously (12).M1 andM2 indicate the vectors
harboring mutations of 5 AP-1 and 3 AP-1 sites, respectively.
pGL3-Il11 (0.8 kb) (605/134) and pGL3-Il11 (0.8 kb,
M1M2) (605/134) were generated by subcloning the PCR-
amplified products containing the indicated fragments using
pGL3-Il11 (1.3 kb) (1094/134) and pGL3-Il11 (1.3 kb,
M1M2) as templates into pGL3-basic vector (Promega). The
following primers were used in this study: pGL3-Il11 (0.8 kb),
5-GGGGGGCTCGAGGTGTATGTACCATCACTCTG-3 and
5-CGGGTCGACACAGGCCAGGGGTTCCCCAGGGCA-
3. An expression vector for Myc-tagged NRF2 was generated
by subcloning of the RT-PCR product of murine Nrf2 into
pcDNA3-myc vector using the following primer: murine Nrf2,
5-GCGCAATTGATGATGATGGACTTGGAGTTGCC-3 and
5-GCGCTCGAGCTAGTTTTTCTTTGTATCTG-3.
HepG2 cells were transfected with the indicated reporter
vector along with pRL-TK vector (Promega) using Lipo-
fectamine 2000. At 24 h after transfection, fresh growth
mediumwas added to the transfection reaction, cells were stim-
ulated with 1,2-NQ for 18 h, and luciferase activities were mea-
sured using the Pica Gene Dual-Luciferase kit (Toyo Ink) on a
Luminometer (Berthold).
ChIP Assay—The ChIP assay was performed as described
previously with slight modification (25). Briefly, HepG2 cells
were unstimulated or stimulated with the indicated concentra-
tions of 1,2-NQ for 2 h. Cells were fixed with 1% formalin for 30
FIGURE 7. Knockdown of NRF2 abolishes expression of Fra-1 at the pro-
tein level, whereas expression of NRF2 induces up-regulation of Fra-1
proteins. A and B, HepG2 cells were transfected with siRNAs as in Fig. 5C and
stimulated with 1,2-NQ (50 M) in the absence or presence of a proteasome
inhibitor,MG132 (10M), for 3 h.A, knockdownofNRF2does not affectmRNA
expression of FOSL1. Relative amounts of FOSL1mRNAs were determined by
qPCR. Results are mean S.D. (error bars) of triplicate samples. ns, not signif-
icant versus control siRNA-transfected cells. B, knockdown of NRF2 abolishes
expression of Fra-1 at the protein level, butMG132 does not block a decrease
in Fra-1 proteins. Cell lysateswere analyzedby immunoblottingwith the indi-
catedantibodies.Topandbottomarrowheads,phosphorylatedandhypophos-
phorylated Fra-1, respectively. Relative ratios of Fra-1/tubulin after the indi-
cated treatment were calculated and are plotted as in supplemental Fig. 2. C,
overexpression of NRF2 induces up-regulation of Fra-1 proteins. HepG2 cells
were transfected with an empty vector or graded amounts (0.2, 0.6, and 2.0
g/sample) of an expression vector for Myc-tagged NRF2, and then cell
lysates were analyzed by immunoblottingwith the indicated antibodies. Rel-
ative ratios of Fra-1/tubulin in cells transfected with the indicated doses of
Myc-tagged NRF2 were calculated and are plotted as in supplemental Fig. 2.
Top and bottom arrowheads, transfected Myc-tagged NRF2 and endogenous
NRF2, respectively. All results are representative of two or three independent
experiments.
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min and then harvested and lysed with a ChIP assay buffer.
After brief sonication by using a Bioruptor II (BM Equipment),
the lysates were immunoprecipitated with control Ig or anti-
NRF2 antibody. After extensive washing, immunoprecipitated
DNA fragments were released and subjected to qPCR. The
primers to amplify the promoter regions of IL11 (177/9)
andNQO1 (429/302) and an unrelated region of theNQO1
(8068/8163) gene were as follows: IL11 (162/80), 5-
GAGCGCGGCGGCGTGAGCCCT-3 and 5-GACACA-
TCCTGACTCACCCT-3; NQO1 (429/302), 5-CATGT-
CTCCCCAGGACTCTC-3 and 5-TTTTAGCCTTGGC-
ACGAAAT-3;NQO1 (8068/8163), 5-CGTGTGTGCTT-
TGTGTGTGT-3 and 5-GCCTCCTTCATGGCATAGTT-
3. The amounts of a target DNA in immunoprecipitates with
control rabbit Ig (Thermo Fisher Scientific) or anti-NRF2 anti-
body were quantified by qPCR using 7500 SDS software
(Applied Biosystems). In brief, the ratios of the amounts of a
target DNA fragment in each immunoprecipitate to those in
the DNAs before immunoprecipitation (input DNA) were
calculated from each cycle threshold value.
CT26 cells were stimulated with H2O2 or 1,2-NQ for 2 h and
subjected to ChIP assays as described above except for using
control Ig or anti-Fra-1 antibody for immunoprecipitation. The
primers to amplify the promoter regions of the murine Il11
(257/206) gene were as follows: Il11 (257/206), 5-
CGGCTCGTCTGAATGGAAAA-3 and 5-TGACACAT-
CCTGACTCACCC-3.
Transient Transfection and Co-immunoprecipitation—
HEK293T cells were transfected with the indicated expression
vectors by polyethyleneimine “Max” (Polysciences). Expression
vectors for FLAG-tagged Fra-1,HA-taggedMEKK1N(consti-
tutive active mutant), and HA-tagged ERK2 were described
previously (12, 26). After an 18-h transfection, cells were lysed
in Buffer A (50 mM Tris-HCl, pH 8.0, 250 mMNaCl, 0.5% Non-
idet P-40, 25mM-glycerophosphate, 1mM sodiumorthovana-
date, 1 mM sodium fluoride, 1 mM PMSF, 1 g/ml aprotinin,
FIGURE 8. Administration of 1,2-NQ enhances apoptosis and proliferation of IECs along with Il11 up-regulation in the cecum of wild-type mice.
Eight-week-oldmalemicewere injectedwith corn oil or 1,2-NQ (2.5 or 5mg/kg). In someexperiments (A, B,C, and E),micewere injectedwith 1,2-NQ (5mg/kg).
Mice were sacrificed, and body weight was measured 72 h after injection. A, changes of body weight are expressed as percentages of initial body weight.
Results are mean S.E. (error bars) (n 8–11 mice). ***, p 0.001 versus corn oil-treated mice. B, H&E-stained cecum sections (n 7–11 mice). Arrowheads,
apoptotic cells. Scale bar, 100 m. C, cecum sections were stained with anti-CC3. Arrows, apoptotic cells. Scale bar, 100 m. D, numbers of CC3-positive
apoptotic cellswere calculatedandare expressedasnumbers of CC3-positive cells per villus (n3–5mice). *,p0.05;ns, not significant versus cornoil-treated
mice. E, cecum sectionswere stainedwith anti-Ki67 and anti-cyclinD1 antibodies (n 5mice). Scale bar, 100m. F, numbers of Ki67-positive proliferating cells
were calculated, and thepercentageof Ki67-positive cells among total epithelial cells is expressed as the labeling index. *,p 0.05 versus corn oil-treatedmice.
G, cecum RNAs were prepared, and relative amounts of Hmox1 and Il11mRNAs were determined by qPCR. Results are means S.E. (n 5 mice). *, p 0.05;
**, p 0.01; ns, not significant versus corn oil-treated mice.
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and 1 g/ml leupeptin). After immunoprecipitation with con-
trol or anti-FLAG antibodies, immunoprecipitates were sub-
jected to SDS-PAGE, and co-immunoprecipitated proteins
were analyzed by immunoblotting with anti-Myc, anti-HA, or
anti-FLAG antibodies. Expression of each transfected protein
in the lysates was verified by immunoblotting with the indi-
cated antibodies.
For transient expression of NRF2, HepG2 cells were trans-
fectedwithMyc-taggedNRF2 as described above. After an 18-h
transfection, cells were lysed in a radioimmune precipitation
assay buffer, and cell lysates were subjected to SDS-PAGE
analysis.
Induction of Peritonitis—8–10-week-old WT, Il11ra1/,
and Il11ra1/ mice were injected intraperitoneally with
1,2-NQ (2.5 or 5.0 mg/kg) that was freshly prepared by using a
Bioruptor II (BM Equipment) just before administration. Mice
were sacrificed 1 or 3 days after injection.
Histological and Immunohistochemical Analyses—Small
intestine, cecum, and colon were fixed in 10% formalin and
embedded in paraffin blocks. Paraffin-embedded intestinal sec-
tions were used for H&E staining. Paraffin-embedded sections
were stained with anti-Ki67, anti-cyclin D1, and anti-cleaved
caspase 3 (CC3) antibodies and visualized with biotin-conju-
gated donkey anti-rabbit IgG antibody and streptavidin-conju-
gated HRP. Pictures were obtained with an all-in-one micro-
scope (BZ-X700, Keyence) and analyzed with Axio version 3.0
(Zeiss).
Statistical Analyses—Statistical analysis was performed by
unpaired Student’s t test. In some experiments that involved
more than two conditions, Tukey’s analysis of variance test was
performed. p values of0.05 were considered to be significant.
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Supplemental Figures 
 
 
 
Supplemental Figure 1. Uncropped images of Western blots with anti-NRF2 antibody used 
in Figure 1A. Red boxes indicate cropped images of Western blots in Figure 1A. 
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Supplemental Figure 2. Kinetics of expression of Fra-1 proteins following 1,2-NQ 
stimulation. CT-26 and HepG2 cells were stimulated and expression of Fra-1 was analyzed as 
in Figure 4. Signals of bands corresponding to Fra-1 and tubulin were quantified by ImageJ 1.49 
software. Relative ratios of signals of Fra-1 versus those of tubulin were calculated and plotted 
at the indicated times, respectively. Relative ratios of Fra-1/tubulin at 0 hour is adjusted to be 
1.0. All results are representative of two independent experiments.  
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Supplemental Figure 3. Knockdown of Junb or Jund does not impair 1,2-NQ-induced Il11 
expression. CT26 cells were transfected with control, Junb, or Jund siRNAs. At 48 hours after 
transfection, cells were unstimulated or stimulated with 1,2 NQ (15 µM) for 3 hours. Expression 
of JunB and JunD in control or the indicated siRNAs-treated cells was analyzed by 
immunoblotting with the indicated antibodies (A, C). Relative amounts of Il11 mRNAs were 
determined by qPCR (B, D). *P < 0.05; **P < 0.01; ***P<0.001 compared to untreated or 
1,2-NQ treated control siRNA-transfected cells. Asterisk indicates non-specific band. All results 
are representative of two independent experiments.  
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Supplemental Figure 4. Kinetics of expression of Fra-1 proteins following electrophile 
stimulation. A, CT26 and HepG2 cells were stimulated with 15d-PGJ2, tBHQ, or 1,2-NQ as in 
Figure 2C, and cell lysates were analyzed by immunoblotting with the indicated antibodies. B, 
Relative ratios of Fra-1/tubulin were calculated, and are expressed as Supplemental Figure 2. 
All results are representative of two to three independent experiments.  
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